Nov 26 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH® ANNOUNCES FIRST PATIENT TREATED IN PHASE 2 STUDY COMBINING PELAREOREP AND KEYTRUDA® IN ADVANCED PANCREATIC CANCER
Nov 26 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH® ANNOUNCES FIRST PATIENT TREATED IN PHASE 2 STUDY COMBINING PELAREOREP AND KEYTRUDA® IN ADVANCED PANCREATIC CANCER